Related Experiment Video
Updated: May 10, 2026

Animal Models of Depression - Chronic Despair Model (CDM)
Published on: September 23, 2021
Intramuscular ketamine in acute depression: A report on two cases
Chilukuri Harihar1, Padmavathy Dasari, Jakka Sriramulu Srinivas
1Department of Psychiatry, Narayana Medical College, Nellore, Andhra Pradesh, India.
Abstract:
It takes about 2 weeks for the onset of antidepressant action of drugs while electroconvulsive therapy though faster, is a cumbersome procedure requiring an anaesthetist and at least a minor operation theatre. Recent studies have shown that Ketamine, when given to severely depressed patients in the dose of 0.5 mg/kg as a slow intravenous infusion over 40 minutes, brought about acute relief from depression and amelioration of suicidal risk within a few hours. The improvement, however, was transient and lasted for up to a week but could be sustained by further weekly or biweekly injections. As the dose of ketamine administered was found to be safe, it was now tried in the intramuscular route in two severely depressed patients with similar rapid improvement. The cases are reported here which pave way for an easier mode of treating acute depression.
Related Concept Videos
Electroconvulsive Therapy
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Antidepressant Drugs: MAOIs and Other Agents
